Niki BioSolutions, Inc. NIKI
1.58 USD +0.08 (+5.33%)
At close·Nov 6, 2026, 4:00 PM EST
1.58 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
- YTD
- -85.09%
- 1 year
- -88.42%
Altman Z-Score
-5.85 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 5
P/E -5.6×
P/S 0.0×
P/B 0.3×
P/FCF -4.2×
EV/EBITDA -4.3×
EV/Sales 0.0×
FCF Yield -23.6%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -5.9%
ROIC -10.4%
ROA -7.3%
Revenue 0.0%
Operating Income 52.1%
EPS (diluted) 75.6%
Free Cash Flow -54.4%
Current Ratio 0.8×
Quick Ratio 0.8×
Debt / Equity 0.1×
Net Debt / EBITDA 0.0×
Interest Coverage -19.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31